Researchers from Harvard Medical School in Boston exposed mice to various strains of a bacterium that causes a range of infections in those with weakened immune systems. Certain strains of the bacterium contained antibiotic-resistant genes, the same kind once thought to hinder the microbes. In this instance, the antibiotic-resistant strains were better than non-resistant strains at infecting the mice.
Resistant strains of bacteria that cause Acinetobacter baumannii, which is a known driver of hospital-acquired infections, were also better-equipped at infecting mice than those without resistant genes.
More articles on infection control:
Infection preventionists approve 11 C. diff prevention recommendations
15 stories on patient, workplace safety
‘Smart’ drug can target site-specific infections
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.